/CNW/ - GSK plc (LSE: GSK) (NYSE: GSK) and BELLUS Health Inc. (TSX: BLU) NASDAQ: BLU) today announced GSK has completed the acquisition of BELLUS, a...
BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“ BELLUS Health ” or the “ Company ”), a clinical-stage biopharmaceutical company working to better the lives of patients suffering from persistent cough,...
Equities in Toronto declined at the open on Wednesday as miners and oil companies tracked commodity ...
Announced that they have entered into an agreement under which GSK will acquire BELLUS, a Canada-based, ...
GSK plc (LSE/NYSE: GSK) and BELLUS Health Inc. (TSX/NASDAQ: BLU) today announced that they have entered into an agreement under which GSK will acquire BELLUS, a Canada-based, late-stage biopharmaceutical...
TORONTO — GSK plc has announced a deal to buy Canadian drug developer Bellus Health Inc. for US$2 billion.
Stocks remained volatile in Canada’s biggest market, but fought their way to positive reading Thursday, ...
Announced positive data from its Phase 1 bioavailability equivalence study evaluating a once-daily Extended-Release ...
BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company working to better the lives of patients suffering from persistent cough,...